Regulus, GSK Ink Second miRNA Rx Collaboration

The newest deal will focus on miRNA-122, with hepatitis C infection as the initial indication.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.